The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 17
- 17 new
- Median first-year cost
- $164,000
- $2,885,312 in all
- Institutions
- 13
- 17 contact PIs
Awards by fiscal year
0
0
0
0
0
0
17
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- DANA-FARBER CANCER INST2
- RESEARCH TRIANGLE INSTITUTE2
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2
- UNIVERSITY OF WASHINGTON2
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
and 8 other institutions
Most frequent study sections
- Special Emphasis Panel (ZRG1 CB-J (70))17
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2020 | Preparation and characterization of radioligands for the orphan receptor GPR881R03AA029013-01 | Hesk, DavidJin, Chunyang | RESEARCH TRIANGLE INSTITUTE, NC | First-year cost $220,241 | Study section ZRG1 |
| FY2020 | Development of Novel Neuropeptide B/W Receptor 1 Agonists1R03TR003370-01 | Nguyen, Thuy | RESEARCH TRIANGLE INSTITUTE, NC | First-year cost $214,589 | Study section ZRG1 |
| FY2020 | Novel genetic dependencies in VRK2 methylated glioblastoma multiforme1R03TR003343-01 | Hahn, William C. | DANA-FARBER CANCER INST, MA | First-year cost $178,000 | Study section ZRG1 |
| FY2020 | Multi-faceted Roles of an Atypical Kinase RIOK2 in Erythropoiesis and Myelodyplastic Syndromes1R03HL156574-01 | Glimcher, Laurie Hollis | DANA-FARBER CANCER INST, MA | First-year cost $177,000 | Study section ZRG1 |
| FY2020 | Illuminating the Metabolic Function of GPR162 by Delineating Downstream Signaling Pathways and Characterizing Hypothalamic Expression Pattern1R03TR003350-01 | Ren, HongxiaWatts, Val J | INDIANA UNIVERSITY INDIANAPOLIS, IN | First-year cost $171,642 | Study section ZRG1 |
| FY2020 | Regulation of KRAS Trafficking and Signaling by GPR311R03TR003358-01 | Philips, Mark Reid | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | First-year cost $169,500 | Study section ZRG1 |
| FY2020 | Structural and functional investigation of the understudied HIPK1 kinase1R03TR003400-01 | Jura, Natalia | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $166,955 | Study section ZRG1 |
| FY2020 | Characterization of an understudied kinase, NEK5, in acquisition of a mesenchymaland migratory cell phenotype1R03TR003386-01 | Burow, Matthew E.Drewry, David Harold | TULANE UNIVERSITY OF LOUISIANA, LA | First-year cost $166,750 | Study section ZRG1 |
| FY2020 | Determination of the subcellular localization of adhesion G protein-coupled receptor B3 (ADGRB3) and its locations of interaction with secreted C1Q-like ligands1R03DC019290-01 | Martinelli, David Christopher | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT | First-year cost $164,000 | Study section ZRG1 |
| FY2020 | Identification of CALHM proteins as ion channels1R03TR003299-01 | Foskett, James Kevin | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $162,083 | Study section ZRG1 |
| FY2020 | The 12-HETE receptor Gpr31 in the -cell pathogenesis of type 1 diabetes1R03TR003381-01 | Mirmira, Raghavendra GTersey, Sarah A. | UNIVERSITY OF CHICAGO, IL | First-year cost $162,000 | Study section ZRG1 |
| FY2020 | Role of HCAR1 in glucose homeostasis1R03TR003313-01 | Jo, Young-Hwan | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | First-year cost $161,587 | Study section ZRG1 |
| FY2020 | Defining biochemical mechanisms of dominant interference by disease-causing variants of TTBK21R03TR003392-01 | Goetz, Sarah | DUKE UNIVERSITY, NC | First-year cost $158,206 | Study section ZRG1 |
| FY2020 | Biochemical approaches to enlighten GPR85 function1R03TR003384-01 | Manglik, Aashish | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $156,226 | Study section ZRG1 |
| FY2020 | Targeted mutagenesis to elucidate the function of understudied ion channels in the central nervous system1R03TR003307-01 | Soden, Marta E | UNIVERSITY OF WASHINGTON, WA | First-year cost $155,500 | Study section ZRG1 |
| FY2020 | Targeting understudied kinases in cancer cell plasticity and drug resistance1R03TR003308-01 | Golkowski, Martin | UNIVERSITY OF WASHINGTON, WA | First-year cost $155,500 | Study section ZRG1 |
| FY2020 | Study of PAK3 in epilepsy-associated defects in synaptic plasticity1R03NS120516-01 | Tsai, Nien-Pei | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | First-year cost $145,533 | Study section ZRG1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.2.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.